• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕早期使用普洛鲁顿长效注射液(己酸羟孕酮)的评估。

Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy.

作者信息

Varma T R, Morsman J

出版信息

Int J Gynaecol Obstet. 1982 Feb;20(1):13-7. doi: 10.1016/0020-7292(82)90039-x.

DOI:10.1016/0020-7292(82)90039-x
PMID:6126401
Abstract

This study evaluates the effect of treatment with Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy, and the final outcome of pregnancy and fetal status. One hundred and fifty patients received intramuscular injection of Proluton-Depot from 6 weeks to 8 weeks to 16 weeks to 18 weeks gestation. The outcome of this treated group was compared with a similar number of 150 patients with similar problems, but the second group received no hormonal treatment. There was no evidence to suggest that Proluton-Depot had any adverse effect on the infant or the final outcome of pregnancy.

摘要

本研究评估了孕早期使用普洛卢通长效注射剂(己酸羟孕酮)治疗的效果以及妊娠的最终结局和胎儿状况。150例患者在妊娠6周-8周、16周-18周时接受了普洛卢通长效注射剂的肌肉注射。将该治疗组的结局与150例有类似问题但未接受激素治疗的患者进行了比较。没有证据表明普洛卢通长效注射剂对婴儿或妊娠的最终结局有任何不良影响。

相似文献

1
Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy.孕早期使用普洛鲁顿长效注射液(己酸羟孕酮)的评估。
Int J Gynaecol Obstet. 1982 Feb;20(1):13-7. doi: 10.1016/0020-7292(82)90039-x.
2
Trial of 17-hydroxyprogesterone caproate (Proluton Depot) in women with long-standing infertility; failure of estrogen positive feedback the following cycle.己酸17-羟孕酮(普洛卢顿长效注射液)治疗长期不孕女性的试验;下一周期雌激素正反馈失败。
Gynecol Endocrinol. 1987 Jun;1(2):177-93. doi: 10.3109/09513598709030681.
3
Transplacental carcinogenesis (adrenocortical carcinoma) associated with hydroxyprogesterone hexanoate.与己酸羟孕酮相关的经胎盘致癌作用(肾上腺皮质癌)
Lancet. 1983 Sep 3;2(8349):580. doi: 10.1016/s0140-6736(83)90616-5.
4
Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.己酸羟孕酮用于双子宫预防早产:一例报告
Horm Mol Biol Clin Investig. 2016 Sep 1;27(3):89-91. doi: 10.1515/hmbci-2015-0060.
5
The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.己酸17α-羟孕酮对现役军人妊娠结局的影响。
Am J Obstet Gynecol. 1983 May 15;146(2):187-90. doi: 10.1016/0002-9378(83)91051-7.
6
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.己酸17-α羟孕酮预防复发性自发性早产疗效的预测因素
Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.
7
Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.与安慰剂相比,对子宫内暴露于己酸17α-羟孕酮的儿童进行随访。
Obstet Gynecol. 2007 Oct;110(4):865-72. doi: 10.1097/01.AOG.0000281348.51499.bc.
8
17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.己酸羟孕酮用于预防复发性自发性早产。
Reprod Toxicol. 2012 Jan;33(1):15-9. doi: 10.1016/j.reprotox.2011.10.017. Epub 2011 Nov 20.
9
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.1936年至1974年明尼苏达州奥尔姆斯特德县子宫内暴露于孕激素的后代中的先天性畸形。
Fertil Steril. 1985 Apr;43(4):514-9. doi: 10.1016/s0015-0282(16)48490-6.
10
Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.己酸17α-羟孕酮与感染风险的关联
Obstet Gynecol. 2015 Jul;126(1):103-8. doi: 10.1097/AOG.0000000000000881.

引用本文的文献

1
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
2
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2017 Oct 31;10(10):CD012024. doi: 10.1002/14651858.CD012024.pub2.
3
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.
EUROmediCAT信号检测:对选定的先天性异常与药物关联的评估
Br J Clin Pharmacol. 2016 Oct;82(4):1094-109. doi: 10.1111/bcp.12947. Epub 2016 Jul 7.
4
The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.孕早期口服地屈孕酮对胎儿心脏发育的影响。
Pediatr Cardiol. 2015 Oct;36(7):1483-8. doi: 10.1007/s00246-015-1190-9. Epub 2015 May 15.
5
Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.己酸17-羟孕酮预防早产:药理学考量
Semin Perinatol. 2014 Dec;38(8):516-22. doi: 10.1053/j.semperi.2014.08.013. Epub 2014 Sep 23.
6
Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.孕酮与己酸17α-羟孕酮不同:对产科实践的启示。
Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30.
7
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.17-羟己酸孕酮在单胎妊娠中的药理学和胎盘转运。
Am J Obstet Gynecol. 2012 Nov;207(5):398.e1-8. doi: 10.1016/j.ajog.2012.08.015. Epub 2012 Aug 16.